104 related articles for article (PubMed ID: 21154314)
1. Nuclear medicine in multiple myeloma -- more than diagnosis.
Cascini GL; Cuccurullo V; Tamburrini O; Mansi L; Rotondo A
Nucl Med Rev Cent East Eur; 2010; 13(1):32-8. PubMed ID: 21154314
[TBL] [Abstract][Full Text] [Related]
2. [New diagnostic imaging approaches in multiple myeloma].
Vaccaro A; Prisco MR; Gatta G; Scialpi M
Recenti Prog Med; 2012 Nov; 103(11):410-6. PubMed ID: 23096722
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine in myeloma: the state of the science and emerging trends.
Sood A; Revannasiddaiah S; Kumar R
Hell J Nucl Med; 2011; 14(1):2-5. PubMed ID: 21512656
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
[TBL] [Abstract][Full Text] [Related]
7. [Whole Body Magnetic Resonance and CT/PET in patients affected by multiple myeloma during staging before treatment].
Falcone C; Cipullo S; Sannino P; Restuccia A
Recenti Prog Med; 2012 Nov; 103(11):444-9. PubMed ID: 23096729
[TBL] [Abstract][Full Text] [Related]
8. [Imaging methods in diagnosis and monitoring of multiple myeloma].
Myslivecek M; Nekula J; Bacovský J
Vnitr Lek; 2006 Nov; 52 Suppl 2():46-54. PubMed ID: 18175429
[TBL] [Abstract][Full Text] [Related]
9. [Classification, staging and prognostic indices for multiple myeloma].
Hotta T
Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
[TBL] [Abstract][Full Text] [Related]
10. [Modern imaging techniques in patients with multiple myeloma].
Bannas P; Kröger N; Adam G; Derlin T
Rofo; 2013 Jan; 185(1):26-33. PubMed ID: 23196838
[TBL] [Abstract][Full Text] [Related]
11. Imaging patients with myeloma.
Winterbottom AP; Shaw AS
Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
[TBL] [Abstract][Full Text] [Related]
12. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
Durie BG
Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
[TBL] [Abstract][Full Text] [Related]
13. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
15. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BG;
Leukemia; 2009 Sep; 23(9):1545-56. PubMed ID: 19421229
[TBL] [Abstract][Full Text] [Related]
16. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
[TBL] [Abstract][Full Text] [Related]
17. Benefits of individual imaging methods for diagnosis and monitoring of activity of multiple myeloma.
Vanicek J; Szturz P; Rehak Z; Kianicka B; Bulik M
Klin Onkol; 2012; 25(3):166-72. PubMed ID: 22724564
[TBL] [Abstract][Full Text] [Related]
18. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
[TBL] [Abstract][Full Text] [Related]
19. [Multiple myeloma. Role of prognostic factors and staging in a therapeutic program].
Bolis S; Bregani ER; Rossini F; Casaroli I; Lanzi E; Maffè P; Baldicchi L; Borin L; Mingozzi S; Tripputi P
Recenti Prog Med; 1994 Jan; 85(1):49-55. PubMed ID: 8184181
[TBL] [Abstract][Full Text] [Related]
20. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
